Vitamin C in the Treatment and Prevention of COVID-19.
Presenter: Richard Cheng, MD, PhD . NIH Webinar (04.08.2020) – This presentation focuses on the role of vitamin C in the treatment and prevention of COVID-19. Current research and preliminary results from clinical trials and practical applications are discussed. Dr. Richard Cheng, MD, PhD, has played an integral role in the development of treatment guidelines currently being used in critical care settings in China.
Vitamin C for the Treatment of Coronavirus (COVID-19) .
Presenter: Paul S. Anderson, NMD . ISOM Webinar (03.19.2020) – This presentation focuses on the role of ascorbate (vitamin C) in the treatment of COVID-19 and its potentially fatal sequela. Pharmacokinetics, safety, and the current scientific literature are reviewed. Clinical applications of oral and intravenous vitamin C are discussed in the context of viral illness.
Front Line COVID-19 Critical Care Alliance (FLCCC) . Formed by leading critical care specialists in March 2020, at the beginning of the Coronavirus pandemic, the ‘Front Line COVID-19 Critical Care Alliance’ is now a 501(c)(3) non-profit organization dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients ill with the disease.
An Orthomolecular Approach to Preventing and Treating Influenza . Presenter: Aileen Burford-Mason, PhD . 48th Orthomolecular Medicine Today Conference (06.02.2019) – Immune function is controlled through nutrient-dependent metabolic pathways and the presence of multiple nutrients that are essential to these pathways is a prerequisite to mounting an effective antiviral defence. Although vaccination may reduce incidence, it does not offer total protection, and efficacy varies from a low of 10% (2004-5) to a high of 60% (2010-11). Evidence suggests that correcting common shortfalls of vitamins, minerals and other nutrients can enhance immune responses to infection and complement current public health approaches to mitigate the incidence and severity of seasonal influenza.
Medications Compromising COVID Infections. Author: Joan-Ramon Laporte, MD . RxISK.org (04.02.2020) – Consumption of various commonly used medicines can increase the risk of pneumonia or pneumonitis by depressing immunity and other protective mechanisms (e.g., immunosuppressive agents, antipsychotic agents, some opioid analgesics, proton pump inhibitors), by causing sedation, which may increase the risk of aspiration, by depressing pulmonary ventilation and favouring the occurrence of atelectasis (e.g., opioid analgesics, anticholinergic drugs, psychotropic agents), or by a combination of these mechanisms. . Translation link: Español
. DISCLAIMER OF INFORMATION & CONTENT
This website contains information pertaining to nutritional intervention and the use of non-patentable molecules for improving outcomes in various medical conditions. The information provided may not reflect the current standard(s) of care in your jurisdiction, and is not intended to be a substitute for medical advice from a licensed physician or other qualified health care professional.
Please consult your regional public health authority for specific guidelines and resources pertaining to the prevention of SARS-CoV-2 / COVID-19